Goldsite COVID-19 SARS-Cov-2 Antigen Kit Passed UK DHSC Phase 3 Evaluation

Goldsite COVID-19 SARS-Cov-2 Antigen Kit (Colloidal Gold) Passed the 3 Phase evaluation of rapid diagnostic assays for specific SARS-CoV-2 antigens (lateral flow devices) in United Kingdom of Department of Health & Social Care (UK DHSC) for its excellent performance, another groundbreaking moment marks it's recognized by global regulatory community, with excellent quality, as always.

Previously, Goldsite's new coronavirus series products have been approved by CE of EU, PEI of Germany, ANSM of France, BfArM of Germany, MHRA of UK, Ministry of Health of Italy, Ministry of Health of Spain and Romania.